论文部分内容阅读
在西方国家,胃癌根治术后的五年生存率仅为20％～30％。此研究旨在评估对新辅助化疗有反应是否能预测可切除胃癌病人的预后。
In western countries, the five-year survival rate after radical gastrectomy is only 20% to 30%. The aim of this study was to evaluate whether response to neoadjuvant chemotherapy can predict the prognosis of patients with resectable gastric cancer.